Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction.

This study was aimed to investigate the significance of absolute concentration of metabolites in glioma patients using proton MR spectroscopy (MRS) with T2 relaxation time correction using three different echo times. The absolute concentrations of metabolites in 7 normal subjects and in 23 gliomas (10 low-grade, 13 high-grade) were obtained by proton MRS using a tissue water signal as an internal standard. The signal intensities of metabolites and tissue water were corrected by T2 relaxation time. In low-grade glioma, the T2 relaxation time of NAA was shorter, and T2 relaxation time of water was prolonged as compared to normal subjects (p < 0.001). In high-grade glioma, the T2 relaxation time of NAA (p < 0.001) and T2 relaxation time of Cr (p < 0.01) were shorter, and T2 relaxation time of water (p < 0.001) was prolonged as compared to normal subjects. Moreover, high-grade gliomas revealed a shorter T2 relaxation time of Cr than low-grade gliomas (p < 0.05). In glioma, NAA and Cr concentration were decreased, and Cho were increased as compared to normal subjects. Moreover, high-grade glioma revealed a significant lower Cr (p < 0.001) and Cho (p < 0.01) concentration compared to low-grade gliomas. Low Cr concentration is the most reliable indicator of malignancy in glioma. Cho concentration did not correlate with malignancy in gliomas.

[1]  V. Simplaceanu,et al.  Tissue water content and nuclear magnetic resonance in normal and tumor tissues. , 1975, Cancer research.

[2]  H. Larsson,et al.  The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.

[3]  D. Leibfritz,et al.  Expression of aquaporins in Xenopus laevis oocytes and glial cells as detected by diffusion-weighted 1H NMR spectroscopy and photometric swelling assay. , 1998, Biochimica et biophysica acta.

[4]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[5]  T Nakada,et al.  Localized proton spectroscopy of focal brain pathology in humans: Significant effects of edema on spin–spin relaxation time , 1994, Magnetic resonance in medicine.

[6]  M. Castillo,et al.  Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[7]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[8]  Hidehiko Kajiwara,et al.  Proton Magnetic Resonance Spectroscopy of Brain TumorsAn In Vitro Study , 1994 .

[9]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[10]  K. Hara,et al.  Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[11]  R. Damadian.  Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.

[12]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[13]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[14]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[15]  A. Marmarou,et al.  Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.

[16]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[17]  B L Miller,et al.  Analysis of brain tumors using 1H magnetic resonance spectroscopy. , 1995, Surgical neurology.

[18]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[19]  T. Yoshimoto,et al.  Intratumoral oxygen pressure in malignant brain tumor. , 1991, Journal of neurosurgery.

[20]  Y. Kinoshita,et al.  Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. , 1994, Neurosurgery.

[21]  A. Mackay,et al.  In vivo measurement of T2 distributions and water contents in normal human brain , 1997, Magnetic resonance in medicine.

[22]  O. Henriksen,et al.  MR-visible water content in human brain: a proton MRS study. , 1994, Magnetic resonance imaging.

[23]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[24]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[25]  J. Hennig,et al.  Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy , 1992, NMR in biomedicine.

[26]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[27]  R. Tarducci,et al.  Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.

[28]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[29]  J R Griffiths,et al.  Tumor metabolism: the lessons of magnetic resonance spectroscopy. , 1995, Advances in enzyme regulation.

[30]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[31]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[32]  H. Poptani,et al.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.

[33]  R. Kauppinen,et al.  Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.

[34]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[35]  R. Edelman,et al.  Magnetic resonance imaging (2) , 1993, The New England journal of medicine.

[36]  A. Falini,et al.  Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives , 1996, Journal of Neurology.

[37]  R. Zimmerman,et al.  Proton MR spectroscopy of pediatric cerebellar tumors. , 1995, AJNR. American journal of neuroradiology.

[38]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[39]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[40]  A. Marmarou,et al.  Microgravimetric analysis of human brain tissue: correlation with computerized tomography scanning. , 1981, Journal of neurosurgery.

[41]  M Brant-Zawadzki,et al.  Cerebral abnormalities: use of calculated T1 and T2 magnetic resonance images for diagnosis. , 1984, Radiology.